Donor transmitted and de novo cancer after liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 20, 2014, Pages 6170-6179

  Desai, Rajeev ^a   Neuberger, James ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cancer; De novo cancer; Donor transmitted cancer; Immunosuppression; Liver transplantation

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; OKT 3; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BRAIN HEMORRHAGE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; COMORBIDITY; DIGESTIVE SYSTEM CANCER; DISEASE TRANSMISSION; DONOR TRANSMITTED CANCER; GLIOBLASTOMA; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; NEOPLASM; NON MELANOMA SKIN CANCER; ORGAN DONOR; PRACTICE GUIDELINE; RISK ASSESSMENT; SUN EXPOSURE; ADVERSE EFFECTS; DONOR; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; NEOPLASMS; PATHOLOGY; POSTOPERATIVE PERIOD; RISK FACTOR; TRANSPLANTATION; TREATMENT OUTCOME;

CENTRAL NERVOUS SYSTEM NEOPLASMS; GRAFT SURVIVAL; GUIDELINE ADHERENCE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; NEOPLASMS; POSTOPERATIVE PERIOD; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84901489814     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i20.6170     Document Type: Article

References (77)

1. Transplant Activity Report: NHS Blood and Transplant; (2013 cited 2013 13 September). Available from: URL: http://www.organdonation.nhs.uk/statistics/transplant_activity_report/
2. Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10: 1889-1896 [PMID: 20659094 DOI: 10.1111/ j.1600-6143.2010.03181.x]
3. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913 [PMID: 15147424 DOI: 10.1111/j.1600-6143.2004.00450.x]
4. Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg 2001; 181: 475-479 [PMID: 11448447 DOI: 10.1016/S0002-9610(01)00595-5]
5. Murray JE, Gleason r, bartholomay a. third report of the human kidney transplant registry. Transplantation 1965; 3: 294-302 [PMID: 14265505 DOI: 10.1097/00007890-196503000-00039]
6. Martin DC, Rubini M, Rosen VJ. cadaveric renal homotransplantation with inadvertent transplantation of carcinoma. JAMA 1965; 192: 752-754 [PMID: 14285706 DOI: 10.1001/ jama.1965.03080220016003]
7. Mcintosh DA, Mcphaul JJ, Peterson EW, Harvin JS, Smith JR, Humphreys JW. homotransplantation of a cadaver neoplasm and a renal homograft. JAMA 1965; 192: 1171-1173 [PMID: 14301046 DOI: 10.1001/jama.1965.03080260059024]
8. Matter B, Zukoski CF, Killen DA, Ginn E. Transplanted carcinoma in an immunosuppressed patient. Transplantation 1970; 9: 71-74 [PMID: 4904755]
9. Barnes AD, Fox M. Transplantation of tumour with a kidney graft. Br Med J 1976; 1: 1442-1444 [PMID: 782642 DOI: 10.1136/bmj.1.6023.1442]
10. Bodvarsson S, Burlingham W, Kusaka S, Hafez GR, Becker BN, Pintar T, Sollinger HW, Albertini MR. Donor-derived small cell lung carcinoma in a kidney transplant recipient. Cancer 2001; 92: 2429-2434 [PMID: 11745300]
11. Loh E, Couch FJ, Hendricksen C, Farid L, Kelly PF, Acker MA, Tomaszewski JE, Malkowicz SB, Weber BL. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997; 277: 133-137 [PMID: 8990338 DOI: 10.1001/jama.1997.0354026004 7034]
12. De Soyza AG, Dark JH, Parums DV, Curtis A, Corris PA. Donor-acquired small cell lung cancer following pulmonary transplantation. Chest 2001; 120: 1030-1031 [PMID: 11555546 DOI: 10.1378/chest.120.3.1030]
13. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl 2003; 9: 1102-1107 [PMID: 14526407 DOI: 10.1053/jlts.2003.50174]
14. Snape K, Izatt L, Ross P, Ellis D, Mann K, O'Grady J. Donor- transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: a rare indication for liver retransplantation. Liver Transpl 2008; 14: 155-158 [PMID: 18236388 DOI: 10.1002/lt.21347]
15. Lipshutz GS, Mihara N, Wong R, Wallace WD, Allen-Auerbach M, Dorigo O, Rao PN, Pham PC, Pham PT. Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient. Am J Transplant 2009; 9: 428-432 [PMID: 19178417 DOI: 10.1111/j.1600-6143.2008.02507.x]
16. Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Cancer transmission from organ donors-unavoidable but low risk. Transplantation 2012; 94: 1200-1207 [PMID: 23269448 DOI: 10.1097/TP.0b013e318272df41]
17. Council of Europe: Guide to the Safety and Quality Assurance for the Transplantation of Organs, Tissues and Cells: Council of Europe; 2010 (cited 2013 16 September). Available from: http://www.edqm.eu/en/blood-organ-guides-1131.html.
18. Nalesnik MA, Woodle ES, Dimaio JM, Vasudev B, Teperman LW, Covington S, Taranto S, Gockerman JP, Shapiro R, Sharma V, Swinnen LJ, Yoshida A, Ison MG. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant 2011; 11: 1140-1147 [PMID: 21645251 DOI: 10.1111/j.1600-6143.2011.03565.x]
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109 [PMID: 17618441 DOI: 10.1007/ s00401-007-0243-4]
20. Watson CJ, Roberts R, Wright KA, Greenberg DC, Rous BA, Brown CH, Counter C, Collett D, Bradley JA. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant 2010; 10: 1437-1444 [PMID: 20486904 DOI: 10.1111/j.1600-6143.2010.03130.x]
21. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/ united network for organ sharing update. Transplantation 2007; 84: 272-274 [PMID: 17667822 DOI: 10.1097/01. tp.0000267919.93425.fb]
22. Neipp M, Schwarz A, Pertschy S, Klempnauer J, Becker T. Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: management and 1 yr follow-up. Clin Transplant 2006; 20: 147-150 [PMID: 16640518 DOI: 10.1111/j.1399-0012.2005.00455.x]
23. Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP, Murray JE. Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 1968; 278: 479-483 [PMID: 4866045 DOI: 10.1056/NEJM196802292780904]
24. Elder GJ, Hersey P, Branley P. Remission of transplanted melanoma--clinical course and tumour cell characterisation. Clin Transplant 1997; 11: 565-568 [PMID: 9408685]
25. Alberú J, Pascoe MD, Campistol JM, Schena FP, Rial Mdel C, Polinsky M, Neylan JF, Korth-Bradley J, Goldberg-Alberts R, Maller ES. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor- free immunotherapy: 24-month results from the CONVERT trial. Transplantation 2011; 92: 303-310 [PMID: 21792049 DOI: 10.1097/TP.0b013e3182247ae2]
26. Mathew T, Kreis H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18: 446-449 [PMID: 15233824 DOI: 10.1111/j.1399-0012.2004.00188.x]
27. Office for National Statistics. Opinions and Lifestyle Survey, Smoking Habits Amongst Adults, 2012: Office for National Statistics; 2013 (cited 2013 29 September). Available from: URL: http://www.ons.gov.uk/ons/search/index.html?pageSize=50&newquery=GeneralLifestyleSurveySmokinganddrinkingamongadults/
28. Office for National Statistics. Chapter 2-Drinking (General Lifestyle Survey Overview - a report on the 2011 General Lifestyle Survey 2013, cited 2013 29 September). Available from: URL: http://www.ons.gov.uk/ons/search/index.html?pageSize=50&newquery=GeneralLifestyleSurveySmokinganddrinkingamongadults/
29. Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901 [PMID: 22045767 DOI: 10.1001/jama.2011.1592]
30. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-1200 [PMID: 9825817 DOI: 10.1097/00007890-199811150-00014]
31. Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 2013; 13: 174-183 [PMID: 23094788 DOI: 10.1111/j.1600-6143.2012.04302.x]
32. Schrem H, Kurok M, Kaltenborn A, Vogel A, Walter U, Zachau L, Manns MP, Klempnauer J, Kleine M. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl 2013; 19: 1252-1261 [PMID: 24106037 DOI: 10.1002/lt.23722]
33. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL. Increased cancer risk after liver transplantation: a population- based study. J Hepatol 2001; 34: 84-91 [PMID: 11211912 DOI: 10.1016/S0168-8278(00)00077-5]
34. Aberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008; 14: 1428-1436 [PMID: 18825704 DOI: 10.1002/lt.21475]
35. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, Sforza D, Miglioresi L, Fantola G, Cimaglia C, Vennarecci G, Vizzini GB, Di Leo A, Rossi M, Tisone G, Zamboni F, Santoro R, Agresta A, Puro V, Serraino D. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc 2013; 45: 2729-2732 [PMID: 24034034 DOI: 10.1016/j.tra nsproceed.2013.07.050]
36. Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, Gambato M, Buda A, Zanus G, Vitale A, De Paoli A, Cimaglia C, Bresadola V, Toniutto P, Risaliti A, Cillo U, Bresadola F, Burra P. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis 2010; 42: 55-60 [PMID: 19497797 DOI: 10.1016/j.dld.2009.04.017]
37. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482-487 [PMID: 12004349 DOI: 10.1053/jlts.2002.32977]
38. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 2002; 8: 939-944 [PMID: 12360438 DOI: 10.1053/jlts.2002.35551]
39. Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001; 72: 619-626 [PMID: 11544420 DOI: 10.1097/00007890-200108270-00010]
40. Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant 2012; 12: 976-983 [PMID: 22226225 DOI: 10.1111/j.1600-6143.2011.03893.x]
41. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS. Epstein- Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356-369 [PMID: 6311121 DOI: 10.1097/00000658-198309000-00012]
42. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492 [PMID: 10944566 DOI: 10.1056/NEJM200008173430707]
43. Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-230 [PMID: 14974943 DOI: 10.1046/ j.1600-6143.2003.00325.x]
44. Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayón M, Mir J, Segura A, Berenguer J. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 596-604 [PMID: 15023152 DOI: 10.1111/ j.1600-6143.2004.00380.x]
45. Duvoux C, Pageaux GP, Vanlemmens C, Roudot-Thoraval F, Vincens-Rolland AL, Hézode C, Gaulard P, Miguet JP, Larrey D, Dhumeaux D, Cherqui D. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002; 74: 1103-1109 [PMID: 12438954 DOI: 10.1097/00007890-200210270-00008]
46. McLaughlin K, Wajstaub S, Marotta P, Adams P, Grant DR, Wall WJ, Jevnikar AM, Rizkalla KS. Increased risk for post- transplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transpl 2000; 6: 570-574 [PMID: 10980055 DOI: 10.1053/jlts.2000.7578]
47. Altieri A, Bosetti C, Gallus S, Franceschi S, Dal Maso L, Talamini R, Levi F, Negri E, Rodriguez T, La Vecchia C. Wine, beer and spirits and risk of oral and pharyngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol 2004; 40: 904-909 [PMID: 15380168 DOI: 10.1016/j.oraloncology.2004.04.005]
48. Testino G. The burden of cancer attributable to alcohol consumption. Maedica (Buchar) 2011; 6: 313-320 [PMID: 22879847]
49. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331-338 [PMID: 8566577 DOI: 10.1053/gast.1996.v110.pm8566577]
50. Sint Nicolaas J, Tjon AS, Metselaar HJ, Kuipers EJ, de Man RA, van Leerdam ME. Colorectal cancer in post-liver transplant recipients. Dis Colon Rectum 2010; 53: 817-821 [PMID: 20389217 DOI: 10.1007/DCR.0b013e3181cc90c7]
51. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl 2012; 18: 1277-1289 [PMID: 22887956]
52. Detry O, Detroz B, D'Silva M, Pirenne J, Defraigne JO, Meurisse M, Honoré P, Michel P, Boniver J, Limet R. Misdiagnosed malignancy in transplanted organs. Transpl Int 1993; 6: 50-54 [PMID: 8452633 DOI: 10.1111/j.1432-2277.1993. tb00746.x]
53. Braun-Parvez L, Charlin E, Caillard S, Ducloux D, Wolf P, Rolle F, Golfier F, Flicoteaux H, Bergerat JP, Moulin B. Gestational choriocarcinoma transmission following multiorgan donation. Am J Transplant 2010; 10: 2541-2546 [PMID: 20977645 DOI: 10.1111/j.1600-6143.2010.03275.x]
54. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 2: 7-12 [PMID: 9869872]
55. Marsh JW, Esquivel CO, Makowka L, Todo S, Gordon RD, Tzakis A, Miller C, Morris M, Staschak S, Iwatsuki S. Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987; 44: 449-450 [PMID: 3307063 DOI: 10.1097/00007890-198709000-00025]
56. Knoop C, Jacobovitz D, Antoine M, de Francquen P, Yernault JC, Estenne M. Donor-transmitted tumors in lung allograft recipients: report on two cases. Transplantation 1994; 57: 1679-1680 [PMID: 8009606]
57. Zelinkova Z, Geurts-Giele I, Verheij J, Metselaar H, Dinjens W, Dubbink HJ, Taimr P. Donor-transmitted metastasis of colorectal carcinoma in a transplanted liver. Transpl Int 2012; 25: e10-e15 [PMID: 22050293 DOI: 10.1111/ j.1432-2277.2011.01380.x]
58. Kim B, Woreta T, Chen PH, Limketkai B, Singer A, Dagher N, Cameron A, Lin MT, Kamel I, Gurakar A. Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature. Dig Dis Sci 2013; 58: 1185-1190 [PMID: 23242807 DOI: 10.1007/s10620-012-2501-0]
59. Kashyap R, Ryan C, Sharma R, Maloo MK, Safadjou S, Graham M, Tretheway D, Jain A, Orloff M. Liver grafts from donors with central nervous system tumors: a single- center perspective. Liver Transpl 2009; 15: 1204-1208 [PMID: 19790151 DOI: 10.1002/lt.21838]
60. Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES. Donors with central nervous system malignancies: are they truly safe? Transplantation 2003; 76: 340-343 [PMID: 12883189 DOI: 10.1097/01.TP.0000076094.64973.D8]
61. Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalmann U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996; 9: 426-429 [PMID: 8819282 DOI: 10.1111/ j.1432-2277.1996.tb00903.x]
62. Morse JH, Turcotte JG, Merion RM, Campbell DA, Burtch GD, Lucey MR. Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm. Transplantation 1990; 50: 875-877 [PMID: 2238063 DOI: 10.1097/00007890-199011000-00026]
63. Zhao P, Strohl A, Gonzalez C, Fishbein T, Rosen-Bronson S, Kallakury B, Ozdemirli M. Donor transmission of pineoblastoma in a two-yr-old male recipient of a multivisceral transplant: a case report. Pediatr Transplant 2012; 16: E110-E114 [PMID: 21281415 DOI: 10.1111/j.1399-3046.2010.01463.x]
64. Harbell JW, Dunn TB, Fauda M, John DG, Goldenberg AS, Teperman LW. Transmission of anaplastic large cell lymphoma via organ donation after cardiac death. Am J Transplant 2008; 8: 238-244 [PMID: 18021286]
65. Kim JK, Carmody IC, Cohen AJ, Loss GE. Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review. Clin Transplant 2009; 23: 571-574 [PMID: 19681978 DOI: 10.1111/j.1399-0012.2008.00928.x]
66. Morris-Stiff G, Steel A, Savage P, Devlin J, Griffiths D, Portman B, Mason M, Jurewicz WA. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004; 4: 444-446 [PMID: 14962000 DOI: 10.1111/ j.1600-6143.2004.00335.x]
67. Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, Bartlett ST, Franklin WA. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000; 70: 232-236 [PMID: 10919612]
68. Cankovic M, Linden MD, Zarbo RJ. Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med 2006; 130: 529-532 [PMID: 16594745]
69. Foltys D, Linkermann A, Heumann A, Hoppe-Lotichius M, Heise M, Schad A, Schneider J, Bender K, Schmid M, Mauer D, Peixoto N, Otto G. Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report. Transplant Proc 2009; 41: 2639-2642 [PMID: 19715991 DOI: 10.1016/j.transproceed.2009.06.026]
70. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl 2011; 17: 83-87 [PMID: 21254348 DOI: 10.1002/lt.22196]
71. Baehner R, Magrane G, Balassanian R, Chang C, Millward C, Wakil AE, Osorio RW, Waldman FM. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Hum Pathol 2000; 31: 1425-1429 [PMID: 11112220 DOI: 10.1016/S0046-8177(00)80015-5]
72. Gerstenkorn C, Thomusch O. Transmission of a pancreatic adenocarcinoma to a renal transplant recipient. Clin Transplant 2003; 17: 473-476 [PMID: 14703934 DOI: 10.1034/ j.1399-0012.2003.00072.x]
73. Detry O, De Roover A, de Leval L, Herens C, Delwaide J, Honoré P, Meurisse M. Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor. Liver Transpl 2005; 11: 696-699 [PMID: 15915495 DOI: 10.1002/lt.20457]
74. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002; 33: 435-436 [PMID: 12055679 DOI: 10.1053/ hupa.2002.124332]
75. Florman S, Bowne W, Kim-Schluger L, Sung MW, Huang R, Fotino M, Thung S, Schwartz M, Miller C. Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation. Am J Transplant 2004; 4: 278-282 [PMID: 14974952 DOI: 10.1046/ j.1600-6143.2003.00322.x]
76. Backes AN, Tannuri AC, de Mello ES, Gibelli NE, de Castro Andrade W, Tannuri U. Transmission of clear cell tumor in a graft liver from cadaveric donor: case report. Pediatr Transplant 2012; 16: E352-E355 [PMID: 22574830 DOI: 10.1111/j.1399-3046.2012.01711.x]
77. Ferreira GF, de Oliveira RA, Jorge LB, Nahas WC, Saldanha LB, Ianhez LE, Srougi M. Urothelial carcinoma transmission via kidney transplantation. Nephrol Dial Transplant 2010; 25: 641-643 [PMID: 20007757 DOI: 10.1093/ndt/gfp612]